D-0728-2026 Class II Ongoing

Recalled by Fresenius Kabi USA, LLC — Lake Zurich, IL

FDA drug recall D-0728-2026 was initiated by Fresenius Kabi USA, LLC on Jul 16, 2026 and is designated Class II. Reason for recall: Presence of Particulate Matter: Hair was found in products The recall status is ongoing. Affected quantity: 93,250 vials.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jul 16, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
93,250 vials

Product description

Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01

Reason for recall

Presence of Particulate Matter: Hair was found in products

Distribution pattern

Nationwide within in the USA

Code information

Lot #: 6130235, Exp. Date 02/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0728-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0728-2026. Report a data issue: hello@regdatalab.com.